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ABSTRACT
The nuclear receptor signaling (NRS) field has gener-
ated a substantial body of information on nuclear
receptors, their ligands and coregulators, with the
ultimate goal of constructing coherent models of
the biological and clinical significance of these
molecules. As a component of the Nuclear Receptor
SignalingAtlas(NURSA)—thedevelopmentofafunc-
tional atlas of nuclear receptor biology—the NURSA
Bioinformatics Resource is developing a strategy to
organize and integrate legacy and future information
on these molecules in a single web-based resource
(www.nursa.org). This entails parallel efforts of (i)
developing an appropriate software framework for
handling datasets from NURSA laboratories and (ii)
designingstrategiesforthecurationandpresentation
of public data relevant to NRS. To illustrate our
approach, we have described here in detail the devel-
opment of a web-based interface for the NURSA
quantitative PCR nuclear receptor expression data-
set, incorporating bioinformatics analysis which pro-
vides novel perspectives on functional relationships
between these molecules. We anticipate that the free
and open access of the community to a platform for
dataminingandhypothesisgenerationstrategieswill
be a significant contribution to the progress of
research in this field.
INTRODUCTION
The ﬁeld of nuclear receptors has made rapid progress over the
last several decades, from the initial characterization of lig-
ands and receptors, to the cloning of receptor cDNAs (1,2), to
the discovery of an ever-increasing number of coregulatory
proteins recruited by receptors to regulate target gene tran-
scription (3,4). More recently, targeted gene deletions com-
bined with transcriptomic analyses have taken steps towards
building a picture of the complex developmental, physiolo-
gical and metabolic networks in which nuclear receptors, their
ligands and coregulators participate. A growing appreciation
of the role of these molecules in tissue homeostasis, aging and
a variety of disease states including diabetes, obesity and
cancer, has made them the focal point of intense clinical
and pharmaceutical interest.
While the development of large public genomic and pro-
teomic database collections such as National Center of Bio-
technology Information (NCBI), UniProt, EBI and others have
facilitated this process, a signiﬁcant deﬁcit remains in the
manner in which data generated by the ﬁeld are integrated,
analyzed and disseminated for the beneﬁt of the entire com-
munity. Traditional hypothesis-driven research modes make it
difﬁcult—if not impossible—to compare between different
datasets.
The Nuclear Receptor Signaling Atlas (NURSA) was
designed by the National Institute of Diabetes and Digestive
and Kidney Diseases, the National Institute on Aging, and the
National Cancer Institute of the NIH to apply discovery-driven
approaches to advance system-wide knowledge in nuclear
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doi:10.1093/nar/gkj029receptor biology [for a primer on NURSA see Margolis
et al. (5)]. The use of novel technologies and discovery-
based high-throughput applications in NURSA are designed
to catalyze traditional hypothesis-driven research by the wider
community.
The NURSA Bioinformatics Resource plays a central role
in the realization of the consortium’s objectives by organizing
these datasets in formats that permit presentation in useful and
interactive ways. The objectives of our resource are 2-fold:
(i) to develop a comprehensive, freely-accessible community
resource,dedicatedtoconsolidatinglegacyandfuturedata
in the nuclear receptor field.
(ii) adopting consistent, sustainable standards in data annota-
tion to facilitate sharing and comparative analyses of data
in the field. Accordingly, we are developing a bioinfor-
matics solution fordata submission, storage,curation, pre-
sentation and mining, with the aim to encourage its
adoptionasaframework forfuture experimental strategies
across the community.
NURSA SYSTEM ARCHITECTURE
In technical terms, the NURSA system architecture represents
an enterprise class, highly scalable and robust ‘3-tier’ archi-
tecture based on the J2EE standard. Raw data is stored accord-
ing to a relational database schema we developed for the
Oracle database management system that runs on Sun hard-
ware hosted at Baylor College of Medicine’s Bioinformatics
Research Center. The application layer uses Oracle Applica-
tion Server and other J2EE server environment components to
provide business logic as well as interfaces to both the
database and the presentation/client layer built in ColdFusion
MX. In practical terms for the user, this architecture translates
to a reliable foundation for data storage (the database), a
ﬂexible infrastructure for rapidly handling user queries (the
business layer) and an intuitive, interactive interface (the pre-
sentation layer).
Key elements of the NURSA information solution that will
be discussed in greater detail here are some components of the
database system and our approach to website design that
emphasizes the ability of the user to readily integrate distinct
datasets and other information sources.
Data sources
The ﬁeld of nuclear receptors is characterized by a broad
compass, a diverse terminology and many intricate functional
relationships, representing a substantial challenge for the
resource in applying a solution for data integration and con-
solidation. The ﬁrst step was to describe data and information
with a structured vocabulary. This is represented by a network
of relational tables designed using guidelines based on the
normalization theory and the concept of constraints to enforce
data integrity (6,7). In this database schema, nuclear receptors,
ligands and coregulators form the three main molecule classes
around which our database schema design is evolving. A
strongly modular character of the developing system ensures
that it retains sufﬁcient ﬂexibility to accommodate a variety of
present and future projects.
Figure 1 illustrates the ﬂow of information within NURSA.
Data are deposited from the following resources:
 high quality experimental data from NURSA laboratories;
 external generic databases with broad genome coverage;
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 NURSA laboratory web pages; and
 submissions to NRS, NURSA’s open access journal.
Curated and generic data is accessible to individual users at
www.nursa.org, as well as being exported to linked databases
such as PubMed Central. We are committed to adopting emer-
ging community standards for data exchange, such as the
Extensible Markup Language (XML)-based frameworks
under development for microarray and molecular interaction
data (8,9). Finally, a central editorial and curatorial team
exercises overall control over the submission, annotation
and distribution of data to and from the website.
NURSA experimental data
NURSA laboratories are developing accelerated throughput
initiatives in applications as diverse as microarray-based
global transcriptomics, real-time quantitative PCR (Q-PCR)
based gene expression analyses (10,11), proteomic and
kinomicproﬁling ofcellular proteins (12)and ligandscreening
(13). Other NURSA initiatives such as siRNA applications
in high-content screening and ChIP-on-Chip assays have
recently been initiated. A central goal of the Bioinformatics
Resource is to integrate these primary datasets to construct
reciprocal models of the interplay between events at the
molecular level (ligand, receptor and coregulator modulation
of target gene expression) and functionality at the organism
level (organ physiology, metabolic regulation and homeo-
stasis). Implicit in this objective is the broader goal of the
consortium to develop improved translational therapies for
intervention in the numerous diseases in which these
molecules are implicated.
External data
External data repositories are mined with the aim of extracting
and presenting information from these databases relevant to
nuclear receptor, their ligands and coregulators. This informa-
tion is used to support primary data derived from the NURSA
laboratories by presenting users with relevant contextual
information, as well as to provide accurate cross-references
to appropriate content in external databases (as shown in
Figure 2). These resources include nucleic acid-based repos-
itories such as the NCBI database collection (with RefSeq,
GenBank and UniGene), the NCBI’s literature resource
PubMed/MEDLINE, protein-based repositories such as the
UniProt/EBI-databases SwissProt and TrEMBL, NucleaRDB,
PIR, InterPro, GOA, Pfam and the protein structure database
PDB, the compound databases PubChem, ChEBI and KEGG,
and portals for species-speciﬁc gene collections such as
MGI (for mouse data), RGD (rat), SGD (yeast), WormBase
(Caenorhabditis elegans) and FlyBase (Drosophila).
NURSA-curated molecules
Molecular data for nuclear receptor ligands, coregulators and
nuclear receptor orthologs from public repositories and liter-
ature databases is NURSA-internally curated and cross-linked
to a content management system built upon the unique identi-
ﬁers for molecules, assays and tissue systems. This ensures
that the user is provided with appropriate contextual informa-
tion. For example, a page displaying a dataset for estrogen
receptor contains links to all other NURSA datasets and jour-
nal articles relevant to that molecule.
We have manually gathered to date 2000 sequences of
each nuclear receptor and coregulator orthologs from a large
variety of species, and will automate the identiﬁcation and
parsing of sequences in the next phase of development to
ensure that only updated information is made available to
the community. Data for the nuclear receptors are organized
by phylogeny to make the information adhere to the suggested
uniﬁed nomenclature system for the NR Superfamily (14).
Coregulators, however, which lack common sequence or
Figure 2. Hyperlinkingthe research community. Screenshots taken from www.nursa.org/ (status July 2005) indicating efficient, intuitive and intelligent browsing.
Curated primary data (large screen) is cross-linked to far-reaching generic information: basic data housed within the NURSA domain (top right) and hyperlinked
content of an external database (PDB in this example, bottom right). Primary NURSA data shown are peptides co-immunoprecipitated by immobilized estrogen
receptor (ESR1, NR3A1)–coactivator CAPER (RNPC2) in HeLa cells (12).
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functional properties, along with a variety of identiﬁable pro-
tein motifs found in other known molecules.
For the nuclear receptor ligands, publicly available data
(e.g. data from ChEBI, KEGG and PubChem) have been aug-
mented in a collaboration with GlaxoSmithKline, which has
provided practical, useful information such as recommended
concentration ranges for ligand studies.
Nuclear receptor signaling
Our PubMed-indexed journal Nuclear Receptor Signaling
(NRS) offers members of the community an opportunity to
contribute to the development of the NURSA website in the
familiar, traditional form of a citable journal article. NRS’s
article architecture is based entirely on the current XML Jour-
nal Publishing Document Type Deﬁnition created by PubMed
Central, the U.S. National Library of Medicine’s permanent
digital archive of biomedical and life sciences journal literat-
ure. The effort invested in designing a PubMed Central-
compliant electronic journal will, we anticipate, be repaid
once NRS articles are listed on PubMed. About 60 million
searches a month are run through the PubMed web interface,
and having NRS content indexed in this database provides a
portal to the NURSA website that would otherwise not exist.
Consistent with NURSA’s commitment to emerging commun-
ity standards in electronic publishing, we have adopted the
Digital Object Identiﬁer (DOI) system (http://www.crossref.
org/), and the Budapest Open Access Initiative (OAI; http://
www.soros.org/openaccess/). The DOI system is designed to
endow digital content with persistence and tangibility associ-
ated with a physical reproduction of this content—such as a
printed journal article. OAI articulates the commitment of its
signatories to the principle of free, less restrictive access to
scientiﬁc data for the entire community.
DATA MINING AND WEBSITE DESIGN
For a website that seeks to establish a broad user base, the
diversity of the nuclear receptor community—basic science,
clinical therapy, pharmaceutical research and development,
and technology transfer agencies—presents its own problems
for the design and functionality of the site. Accordingly, we set
out to develop a user interface based upon fundamental prin-
ciples of web navigation, incorporating navigational elements
that would provide for efﬁcient, intuitive and intelligent
browsing and searching of site content. Figure 2 illustrates
how users are given the option, when viewing a primary
NURSA dataset, to explore relevant information in external
databases using numerous hyperlinks. In this example, pro-
teins co-immunoprecipitated by immobilized estrogen recep-
tor (ESR1, NR3A1)–coactivator CAPER (RNPC2) are shown
bypresenting the raw data (gel picture) as well as by listing the
identiﬁed proteins. These proteins are linked into a large pool
of generic data for the selected molecule, and, with only one
more mouse click, the user can access the information in the
external repository (as shown with the structure of the SNRPD
core domain 1 at PDB in this case).
In addition to presenting primary data, the resource is also
developing approaches to ﬁnding patterns, trends and relation-
ships in the NURSA datasets that would not be apparent to the
user when viewing individual experiments. The net effect of
such efforts will be to work discrete datasets into a collective
framework for making decisions, conﬁrming directions and
validatingapproaches—effectively placing theuseronanother
level with respect to understanding the data.
To illustrate this with an example of what this means for the
user in practical terms, Figure 3 shows a data analysis model
we developed for the quantitative real-time PCR-based survey
of the anatomical expression proﬁles of 49 nuclear receptors in
39 tissues in two mouse strains (15). Our objectives with
regard to this dataset were to allow for the identiﬁcation of
similar expression proﬁles and to reveal unique nuclear
receptor/tissue distribution patterns using objective analytical
clustering combined with data correlation matrices. Each cor-
relation matrix represents clustered nuclear receptor expres-
sion data from the two mouse strains analyzed in
superimposed arrays. The normalized expression data from
the 129x1/SvJ strain was color-coded in red and arranged
in perpendicular arrays; C57Bl/6J results were color-coded
green and also arranged as a matrix, and both square arrays
subsequently superimposed to form a single correlation mat-
rix. Because data were computed for nuclear receptors as well
as for tissues, two distinct correlation matrices are generated,
onefornuclearreceptorandonefortissues(Figure3showsthe
matrix for nuclear receptors).
In such a correlation matrix, the yellow color is the result of
equal distribution of red and green data, indicating comparable
relative levels of expression in both strains. Color shifts
towards green or red indicate predominance of either of the
two strains. Besides the deviations in the expression pattern
between strains, the matrix also gives a perspective on the
relative expression levels, since we plotted arrays of normal-
ized expression values to render the color intensity of each
element within the matrix proportional to the strength of the
correlation. In practical terms, the matrices give the user, in a
single illustration, an overall ‘high-level’ perspective of the
entire Q-PCR dataset. Because matrix annotations have been
linked to a side-by-side display of the expression proﬁles of
the selected nuclear receptor, such ‘at-a-glance’ representa-
tions of comprehensive information allow for a rapid data
access. The user is again provided with multifaceted informa-
tion and access options via an intuitive interface on the
NURSA website.
CONCLUSION
We have described here a suite of features, both existing and
under development, which are designed to add value to and
enrich the experience of members of the nuclear receptor
community. The concept of a specialist nuclear receptor data-
base such as NURSA is predicated on the argument that such
initiatives, with a more focused compass than larger generic
resources, as well as a closer relationship with their respective
ﬁelds of expertise, are positioned to provide a level of annota-
tion that is not practicable for larger databases. Whether this
argument is valid will ultimately be tested by the response of
the community to the NURSA website and its content. Ulti-
mately, our goal is to provide a platform for organizing and
integrating the diverse data sources of this ﬁeld into a frame-
work to allow for better approaches to understanding the bio-
logy of nuclear receptors.
D224 Nucleic Acids Research, 2006, Vol. 34, Database issueFigure 3. Dataminingeffortsforintegratedsolutions.Combinedcorrelationmatrix(CM)forthe Q-PCRanatomicalexpressionprofilingdatasetformousenuclear
receptors along withthe results of clusteranalysis (CA) and data integration(SD) allow for ‘at-a-glance’ interpretations of a comprehensive dataset as well as rapid
dataaccess.Thelaterisillustratedbya screenshot (SS),whichshowsaside-by-siderepresentationoftheexpressionprofilesofER-alpha in39tissuesof129x1/SvJ
and C57Bl/6 mice (see text for details).
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